United Therapeutics Corporation UTHR Balance Sheet

United therapeutics corporation (UTHR)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Dec'09
Assets
Current assets:
Cash and cash equivalents
875	738	719	881	790	669	656	745	932	705	1,067	1,005	1,122	1,023	953	837	846	831	765	254	426	397	497	259	413	284	322	343	262	154	263	157	156	162	343	321	288	252	210	285	100
Marketable investments
669	747	850	904	814	746	581	467	324	222	143	109	33	27	79	107	128	122	156	185	230	297	270	308	346	409	394	353	408	325	240	235	252	240	350	409	394	374	251	94	129
Accounts receivable, no allowance for 2020 and 2019
149	151	183	181	159	175	215	251	211	297	251	273	188	214	224	238	194	192	179	169	156	162	139	212	131	126	130	131	101	116	108	98	89	88	87	82	65	73	75	83	50
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	12	-	13	-	-	9	9	10	12	8	7	9	8
Inventories, net
92	93	94	96	96	101	101	102	101	107	114	114	106	100	92	89	87	81	80	77	72	66	63	58	51	47	49	44	39	37	46	46	45	45	45	41	38	35	33	30	26
Other current assets
60	133	85	75	81	75	54	57	64	115	62	60	52	59	36	43	42	47	46	142	108	32	107	43	46	46	35	5	5	35	37	24	21	6	6	11	9	6	8	2	2
Deferred tax assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14	14	-	8	8	8	8	2	2	2	12	11	10	7
Total current assets
1,846	1,864	1,933	2,139	1,942	1,768	1,608	1,624	1,633	1,447	1,639	1,563	1,504	1,424	1,386	1,315	1,299	1,275	1,228	829	994	957	1,078	881	990	914	932	903	844	668	718	570	573	562	846	877	810	764	598	516	324
Marketable investments
868	767	730	420	411	442	595	578	414	502	338	216	144	2	2	3	10	38	91	121	116	122	205	280	384	448	321	198	206	305	248	308	336	343	249	157	141	132	164	135	148
Marketable investments and cash-restricted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	-	5	5	5	5	5	5	5	5	5	5	5	5	40	40	39
Goodwill and other intangible assets, net
158	158	158	161	170	170	167	45	45	45	45	45	33	33	34	34	34	28	28	28	29	29	14	15	13	14	14	14	15	16	16	17	24	22	19	9	9	9	16	16	18
Property, plant and equipment, net
739	738	678	709	701	699	665	626	577	545	521	501	493	489	488	490	495	495	474	471	474	478	481	477	474	464	449	447	449	453	439	435	401	366	333	314	304	306	303	302	303
Deferred tax assets, net
246	230	268	264	265	95	112	113	113	113	177	178	181	178	188	188	192	192	182	182	182	198	193	193	193	192	149	149	149	150	190	190	190	190	191	193	192	202	151	169	200
Other non-current assets
168	154	231	202	235	224	261	257	235	224	213	185	204	197	169	169	159	154	153	102	97	97	98	103	53	53	53	57	26	26	28	28	28	27	22	21	20	11	8	7	15
Total assets
4,025	3,913	3,999	3,898	3,726	3,401	3,412	3,244	3,020	2,879	2,936	2,691	2,561	2,325	2,269	2,201	2,192	2,184	2,159	1,736	1,894	1,884	2,072	1,952	2,114	2,087	1,927	1,777	1,697	1,626	1,647	1,556	1,561	1,518	1,667	1,578	1,485	1,431	1,282	1,187	1,051
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued expenses
130	148	161	163	139	166	204	216	203	171	143	126	105	104	119	124	106	103	113	110	90	85	127	112	104	92	97	-	-	83	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	10	-	10	8	8	47	17	17	10	16	11	9	18
Accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	81	67	-	87	67	58	57	69	61	52	50	45	41	29
Convertible notes at carrying value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	5	-	30	32	115	126	224	221	218	215	212	210	-	-	-	-	-	-	248	244	240	235	231	227	220
Share tracking awards plan
32	25	18	17	77	72	89	71	82	240	145	192	218	194	134	120	142	274	214	354	392	282	301	164	207	287	-	-	-	75	-	-	-	-	-	-	-	-	-	-	-
Line of credit and mortgages payable-current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	66	141	66	66	-	-	-	1	-	-	-	-	-	-	-	-	-	-	-
Lease obligation-current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31	30	-
Other current liabilities
45	39	40	31	53	38	77	62	32	33	251	270	104	33	60	46	103	62	199	45	48	10	39	19	61	25	158	110	99	16	129	111	108	108	89	130	139	126	77	55	61
Total current liabilities
207	463	469	463	270	276	372	350	318	444	789	838	427	332	314	292	357	440	557	542	646	504	760	659	658	687	468	412	176	176	227	187	175	212	424	453	441	428	397	365	330
Line of credit (non-current)
800	600	750	800	1,050	250	250	250	250	250	250	250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current liabilities
-	-	-	-	-	-	-	-	-	-	57	57	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	207	204	201	199	196	194	-	-	-	-	-	-	-
Mortgages payable-noncurrent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	-	70	70	70	70	71	71	71	71	68	68	68	68	-	-	-
Lease obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30
Other non-current liabilities
70	70	63	68	68	66	77	60	63	63	-	-	57	130	105	92	112	144	122	140	135	114	94	80	95	95	80	78	81	79	74	77	82	80	77	43	39	39	33	28	27
Total liabilities
1,077	1,133	1,283	1,332	1,388	593	700	660	631	758	846	896	485	463	419	384	469	584	679	683	782	618	855	739	757	783	619	561	535	531	575	535	525	558	571	565	550	536	431	394	387
Commitments and contingencies-Note 13
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	-	-	-
Temporary equity
-	-	-	8	19	19	19	19	19	19	19	19	10	10	10	10	11	11	12	13	20	23	36	39	42	45	47	50	-	10	-	-	-	-	-	-	-	-	-	-	-
Stockholders' equity:
Common stock subject to repurchase
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	-	10	10	10	10	10	10	10	10	10	10	10
Common stock, par value $.01, 245,000,000 shares authorized, 70,621,284 and 70,503,775 shares issued, and 44,002,068 and 43,884,559 shares outstanding at March 31, 2020 and December 31, 2019, respectively
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital
2,068	2,047	2,025	2,001	1,967	1,940	1,924	1,903	1,879	1,854	1,838	1,785	1,801	1,813	1,836	1,826	1,801	1,790	1,723	1,694	1,426	1,376	1,161	1,101	1,076	1,057	1,029	999	1,028	1,015	1,013	998	996	992	959	958	953	928	892	874	798
Accumulated other comprehensive loss
-3	-14	-4	-5	-5	-7	-22	-21	-21	-19	-16	-16	-16	-16	-16	-14	-19	-20	-21	-19	-21	-16	-16	-14	-15	-13	-15	-17	-16	-14	-9	-10	-9	-10	-10	-8	-7	-9	-6	-7	-4
Treasury stock, 26,619,216 shares at March 31, 2020 and December 31, 2019
2,579	2,579	2,579	2,579	2,579	2,579	2,579	2,579	2,579	2,579	2,579	2,543	2,326	2,379	2,305	2,167	2,025	1,902	1,850	1,785	1,365	1,185	916	890	611	513	513	513	476	470	413	370	282	282	70	70	70	67	67	67	67
Retained earnings
3,462	3,325	3,272	3,140	2,935	3,434	3,369	3,263	3,090	2,845	2,826	2,550	2,606	2,433	2,323	2,161	1,955	1,719	1,615	1,150	1,051	1,068	952	977	865	728	758	695	615	553	470	392	319	249	205	121	47	31	21	-18	-74
Total stockholders' equity
2,948	2,780	2,715	2,558	2,319	2,788	2,692	2,565	2,369	2,101	2,069	1,776	2,065	1,851	1,838	1,806	1,711	1,588	1,466	1,040	1,091	1,242	1,180	1,173	1,315	1,259	1,260	1,165	1,150	1,083	1,060	1,009	1,024	948	1,084	1,002	924	883	840	782	653
Total liabilities and stockholders' equity
4,025	3,913	3,999	3,898	3,726	3,401	3,412	3,244	3,020	2,879	2,936	2,691	2,561	2,325	2,269	2,201	2,192	2,184	2,159	1,736	1,894	1,884	2,072	1,952	2,114	2,087	1,927	1,777	1,697	1,626	1,647	1,556	1,561	1,518	1,667	1,578	1,485	1,431	1,282	1,187	1,051